Skip to main content

Advertisement

Log in

Association of serum chloride level with mortality and cardiovascular events in chronic kidney disease: the CKD-ROUTE study

  • Original Article
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

Background

Electrolyte abnormalities, particularly dysnatremia, are independent predictors of adverse outcome in individuals with and without renal failure. However, the association of serum chloride level (Cl) with mortality or risk of cardiovascular (CV) events in chronic kidney disease (CKD) remains unclear.

Methods

This prospective cohort study included 923 pre-dialysis CKD G2–G5 patients among the participants of the CKD Research of Outcomes in Treatment and Epidemiology (CKD-ROUTE) study, who newly visited 16 nephrology centers. The primary outcome was a composite of overall death and CV events, and the secondary outcome was overall death. Data were analyzed using the Cox hazards model with adjustment for potential confounders.

Results

Median Cl was 106.0 mEq/L at enrollment [quartile (Q) 1: ≤103.9, n =  207; Q2: 104.0–105.9, n =  207; Q3: 106.0–108.0, n =  289; Q4: ≥108.1, n = 220]. During a median follow-up of 33 months, there were 98 CV events, 66 deaths, and 154 composite outcomes. The hazard ratio (HR) for the composite outcome was higher for Q1 than Q3 [HR 1.72; 95 % confidence interval (CI) 1.08–2.72; P =  0.022]. As a continuous variable in a subset of patients whose Cl was ≤106.0 mEq/L, higher Cl was associated with lower risk of the composite outcome (HR 0.93; 95 % CI 0.87–0.99; P = 0.023). HR for all-cause mortality was also higher for Q1 than Q3 (HR 2.48; 95 % CI 1.22–5.03; P =  0.012).

Conclusion

Low Cl was associated with increased mortality and risk of CV events in pre-dialysis CKD patients. Cl may be an additional prognostic indicator in CKD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Waikar SS, Mount DB, Curhan GC. Mortality after hospitalization with mild, moderate, and severe hyponatremia. Am J Med. 2009;122:857–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Gheorghiade M, Rossi JS, Cotts W, et al. Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial. Arch Intern Med. 2007;167:1998–2005.

    Article  PubMed  Google Scholar 

  3. Liamis G, Rodenburg EM, Hofman A, Zietse R, Stricker BH, Hoorn EJ. Electrolyte disorders in community subjects: prevalence and risk factors. Am J Med. 2013;126:256–63.

    Article  CAS  PubMed  Google Scholar 

  4. Bowling CB, Pitt B, Ahmed MI, et al. Hypokalemia and outcomes in patients with chronic heart failure and chronic kidney disease: findings from propensity-matched studies. Circ Heart Fail. 2010;3:253–60.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Nakhoul GN, Huang H, Arrigain S, et al. Serum potassium, end-stage renal disease and mortality in chronic kidney disease. Am J Nephrol. 2015;41:456–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Eustace JA, Astor B, Muntner PM, Ikizler TA, Coresh J. Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease. Kidney Int. 2004;65:1031–40.

    Article  CAS  PubMed  Google Scholar 

  7. Hecking M, Karaboyas A, Saran R, et al. Predialysis serum sodium level, dialysate sodium, and mortality in maintenance hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2012;59:238–48.

    Article  CAS  PubMed  Google Scholar 

  8. Kovesdy CP, Lott EH, Lu JL, et al. Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure. Circulation. 2012;125:677–84.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Stevens LA, Djurdjev O, Cardew S, Cameron EC, Levin A. Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes. J Am Soc Nephrol. 2004;15:770–9.

    Article  CAS  PubMed  Google Scholar 

  10. Lacson E Jr, Wang W, Ma L, Passlick-Deetjen J. Serum magnesium and mortality in hemodialysis patients in the United States: a Cohort Study. Am J Kidney Dis 2015. doi: 10.1053/j.ajkd.2015.06.014.

  11. Kurtz TW, Morris RC Jr. Dietary chloride as a determinant of “sodium-dependent” hypertension. Science. 1983;222:1139–41.

    Article  CAS  PubMed  Google Scholar 

  12. Shaw AD, Raghunathan K, Peyerl FW, Munson SH, Paluszkiewicz SM, Schermer CR. Association between intravenous chloride load during resuscitation and in-hospital mortality among patients with SIRS. Intensive Care Med. 2014;40:1897–905.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA. 2012;308:1566–72.

    Article  CAS  PubMed  Google Scholar 

  14. Wilcox CS. Regulation of renal blood flow by plasma chloride. J Clin Invest. 1983;71:726–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Zhang Z, Xu X, Fan H, Li D, Deng H. Higher serum chloride concentrations are associated with acute kidney injury in unselected critically ill patients. BMC Nephrol. 2013;14:235.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Iimori S, Noda Y, Okado T, et al. Baseline characteristics and prevalence of cardiovascular disease in newly visiting or referred chronic kidney disease patients to nephrology centers in Japan: a prospective cohort study. BMC Nephrol. 2013;14:152.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Iimori S, Naito S, Noda Y, et al. Anaemia management and mortality risk in newly visiting patients with chronic kidney disease in Japan: the CKD-ROUTE study. Nephrology (Carlton). 2015;20:601–8.

    Article  CAS  PubMed  Google Scholar 

  18. Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67:2089–100.

    Article  PubMed  Google Scholar 

  19. Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.

    Article  CAS  PubMed  Google Scholar 

  20. Japanese Society of Nephrology. Evidence-based practice guideline for the treatment of CKD. Clin Exp Nephrol. 2009;13:537–66.

    Article  Google Scholar 

  21. Japanese Society of Nephrology. Special issue: clinical practice guidebook for diagnosis and treatment of chronic kidney disease 2012 [in Japanese]. Nihon Jinzo Gakkai shi. 2012;54:1034–191.

    Google Scholar 

  22. Skøtt O, Briggs JP. Direct demonstration of macula densa-mediated renin secretion. Science. 1987;237:1618–20.

    Article  PubMed  Google Scholar 

  23. Waikar SS, Curhan GC, Brunelli SM. Mortality associated with low serum sodium concentration in maintenance hemodialysis. Am J Med. 2011;124:77–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Cioffi G, Mortara A, Di Lenarda A, et al. Clinical features, and in-hospital and 1-year mortalities of patients with acute heart failure and severe renal dysfunction. Data from the Italian Registry IN-HF Outcome. Int J Cardiol. 2013;168:3691–7.

    Article  PubMed  Google Scholar 

  25. De Bacquer D, De Backer G, De Buyzere M, Kornitzer M. Is low serum chloride level a risk factor for cardiovascular mortality? J Cardiovasc Risk. 1998;5:177–84.

    Article  PubMed  Google Scholar 

  26. McCallum L, Jeemon P, Hastie CE, et al. Serum chloride is an independent predictor of mortality in hypertensive patients. Hypertension. 2013;62:836–43.

    Article  CAS  PubMed  Google Scholar 

  27. Raphael KL, Zhang Y, Wei G, Greene T, Cheung AK, Beddhu S. Serum bicarbonate and mortality in adults in NHANES III. Nephrol Dial Transplant. 2013;28:1207–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Dobre M, Yang W, Chen J, et al. CRIC Investigators: association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study. Am J Kidney Dis. 2013;62:670–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eiichiro Kanda.

Ethics declarations

Conflict of interest

None to declare.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 207 kb)

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mandai, S., Kanda, E., Iimori, S. et al. Association of serum chloride level with mortality and cardiovascular events in chronic kidney disease: the CKD-ROUTE study. Clin Exp Nephrol 21, 104–111 (2017). https://doi.org/10.1007/s10157-016-1261-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-016-1261-0

Keywords

Navigation